Mark Yarchoan, MD

Mark Yarchoan, MD

Articles by Mark Yarchoan, MD

Feasibility of Personalized Neoantigen Vaccines Plus Pembrolizumab for Advanced HCC

Mark Yarchoan, MDUnresectable HCC | May 15, 2024

Dr. Yarchoan details neoantigen-specific T cell responses assessed in the study.